Concettina La Motta - Concepedia

Author

Concettina La Motta

Also Known As

C La Motta, C. LA MOTTA, C. La Motta, C. Motta, Concettina La Motta, Concettina La-Motta, Concettina La Motta, Concettina la Motta, La Motta C, La Motta, Concettina

257

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Pisa University of Naples Federico II University of Siena Sapienza University of Rome University of Florence

About

Concettina La Motta is an author at University of Pisa specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	46	1.6K
2	Natural Sciences	22	29	1K
3	Engineering	5	5	133
4	Education	1	1	35
5	Allergy	1	1	18

Concettina La Motta

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells Peng Cheng, Jia Wang, Indrayani Waghmare, Cancer Research Transcriptional RegulationDevelopmental BiologyFoxd1–aldh1a3 SignalingTherapeutic ResistanceMedicine	2016	182
Pyrido[1,2-<i>a</i>]pyrimidin-4-one Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors Exhibiting Antioxidant Activity Concettina La Motta, Stefania Sartini, Laura Mugnaini, Journal of Medicinal Chemistry	2007	145
Sampling protein motion and solvent effect during ligand binding Vittorio Limongelli, Luciana Marinelli, Sandro Cosconati, Proceedings of the National Academy of Sciences	2012	120
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications Rosaria Ottanà, Rosanna Maccari, Marco Giglio, European Journal of Medicinal Chemistry 5-Arylidene-4-thiazolidinone DerivativesMedicinal ChemistryAntioxidant AgentsAldo-keto ReductaseBiochemistry	2011	110
Inhibition of Adenosine Deaminase Attenuates Inflammation in Experimental Colitis Luca Antonioli, Matteo Fornai, Rocchina Colucci, Journal of Pharmacology and Experimental Therapeutics	2007	109
Anxiolytic-like Effects of<i>N</i>,<i>N</i>-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis Federico Da Settimo, Francesca Simorini, Sabrina Taliani, Journal of Medicinal Chemistry	2008	76
Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer Alessandro Antonelli, Guido Bocci, Concettina La Motta, The Journal of Clinical Endocrinology & Metabolism	2010	67
How Reliable Are Current Docking Approaches for Structure‐Based Drug Design? Lessons from Aldose Reductase Matthias Zentgraf, H. Steuber, C. Koch, Angewandte Chemie International Edition Drug TargetAldo-keto ReductaseBiomolecular Structure PredictionMolecular BiologyChemical Biology	2007	62
Synthesis of pyrrolo[3,4-c]pyridine derivatives possessing an acid group and their in vitro and in vivo evaluation as aldose reductase inhibitors A. DA SETTIMO, Giampaolo Primofiore, Federico Da Settimo, European Journal of Medicinal Chemistry Medicinal ChemistryAldo-keto ReductaseBiochemistryAcid GroupVivo Evaluation	1996	61
Imidazo[1,2-<i>a</i>]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells Luca Quattrini, Edoardo Luigi Maria Gelardi, Vito Coviello, Journal of Medicinal Chemistry	2020	61

Page 1